Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience

BACKGROUND: It is critically important to study the real-world data of FDA-approved medications to understand the response rates and toxicities observed in the real-world population not represented in the clinical trials. METHODS: We reviewed charts of patients diagnosed with metastatic, hormone rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Alaklabi, Sabah, Roy, Arya Mariam, Attwood, Kristopher, George, Anthony, O’Connor, Tracey, Early, Amy, Levine, Ellis G., Gandhi, Shipra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631302/
https://www.ncbi.nlm.nih.gov/pubmed/36338738
http://dx.doi.org/10.3389/fonc.2022.1012391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631302/
https://www.ncbi.nlm.nih.gov/pubmed/36338738
http://dx.doi.org/10.3389/fonc.2022.1012391

Ejemplares similares